Trial Profile
Phase II Multicenter Study in the Preoperative Treatment of Gastric Adenocarcinoma Consisting of Chemotherapy Using Docetaxel-cisplatin-5FU + Lenograstim Followed by Chemoradiation Based 5FU and Oxaliplatin
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms NESC
- 21 Jan 2017 Results (n=33) presented at the 2017 Gastrointestinal Cancers Symposium
- 05 Apr 2012 New trial record